baber/WOPTO huggingface dataset:
Patent NZ-586576-A (NZ)
Title: Improved mammalian expression vectors and uses thereof
Inventor: HSIEH CHUNG-MING
IPC: C12P21/06
Filed: 2009-01-15
Abstract: An expression vector that comprises: (a) An OriP origin of replication from Epstein-Barr virus (EBV); (b) And SV40 origin of replication; (c) An insertion site for a gene of interest; (d) An EF-1alpha promoter operably linked to the insertion site; and optionally (e) A nucleic acid sequence encoding an antibody. The antibody can be an anti-TNFalpha antibody, an anti-IL-18 antibody or and anti-IL-12 antibody. The vector can be used to express the antibody in a mammalian host cell selected from COS or HEK-293-6E cells.
Patent NZ-586616-A (NZ)
Title: Prognosis Prediction For Colorectal Cancer
Inventor: REEVE ANTHONY E
IPC: G16B25/10
Filed: 2006-12-22
Abstract: Provided is a method for determining the prognosis of colorectal cancer (CRC) in a patient, the prognosis being the likelihood of recurrence of the CRC, comprising the steps of: (i) determining the expression level of a prognostic signature comprising DLGAP4 in a CRC tumour sample from the patient, and (ii) establishing a prognosis by comparing the expression level of the prognostic signature to those of known recurrent and non-recurrent tumour samples.
Patent NZ-586934-A (NZ)
Title: Building support system with spacer bracket penetrating insulation
Inventor: LUTKAJTIS MICHAEL
IPC: E04D13/16
Filed: 2010-07-21
Abstract: A roofing support system is disclosed including a spacer bracket having a lower edge adapted to pierce through a layer of insulation to abut in direct contact with a purlin, and fastening means for fastening the spacer bracket to the purlin, and an upper portion adapted to support a beam above the insulation layer and in spaced relationship to the purlin.
Patent NZ-587608-A (NZ)
Title: Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease
Inventor: SCARPA SIGFRIDO
IPC: A61K31/7076
Filed: 2009-02-25
Abstract: Disclosed is the use of S-adenosylmethionine (SAM) in combination with superoxide dismutase (SOD) for the preparation of medicaments for the treatment of Alzheimer's disease.
Patent NZ-588517-A (NZ)
Title: water turbine with a turbine shroud inlet having a non-circular cross-sectional area
Inventor: PRESZ WALTER M
IPC: F03B13/10
Filed: 2009-04-16
Abstract: 588517 Disclosed is a water turbine system. The system has a rotor assembly that is axially symmetric about an axis of rotation and has an upstream rotor face. The system further has a turbine shroud (102) within which at least a portion of the rotor assembly is disposed, the turbine shroud (102) comprising a turbine shroud inlet and a turbine shroud terminus. The turbine shroud terminus has a plurality of turbine shroud mixer elements (120a), and the turbine shroud inlet has a non-circular cross-sectional area. The system further has an ejector shroud (128) within which at least a portion of the turbine shroud (102) is disposed, the ejector shroud (128) comprising an ejector shroud inlet and an ejector shroud terminus.
Patent NZ-589302-A (NZ)
Title: Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
Inventor: BONNIN DUSTAN
IPC: A61K39/145
Filed: 2009-04-17
Abstract: Disclosed is a process for the solid phase synthesis of directed epitope peptide mixtures useful in the treatment and diagnosis of protein conformational disorders, such process defined by a set of rules regarding the identity and the frequency of occurrence of amino acids that substitute a base or native amino acid of a known epitope. The resulting composition is a mixture of related peptides for therapeutic use. Further disclosed is a process of generating antibodies using the directed epitope peptide mixtures as the antigens, and antibodies generated by such process, useful in the treatment and diagnostics of the said protein conformational disorder.
Patent NZ-591985-A (NZ)
Title: Stock effluent treatment system witheffluent passed through first filter, first storage pond, second filter, second storage pond and third filter
Inventor: PLUCK NEIL GRAHAM EDWARD
IPC: A01C3/00
Filed: 2011-03-29
Abstract: Stock effluent is passed sequentially through first filter 2, first storage pond 3, second filter 5, second storage pond 6 and third filter 8. Typically, stirrers 4, 7 are provided in respective ponds 3, 6.
Patent NZ-598751-A (NZ)
Title: Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance (bifidobacterium breve mcc1274 (ferm bpp-11175))
Inventor: KONDO SHIZUKI
IPC: C12R1/01
Filed: 2010-09-17
Abstract: Disclosed is a bacterial strain Bifidobacterium breve MCC 1274 (FERM BP-11175). Also disclosed is the use of a bacterial strain selected from the group consisting of Bifidobacterium breve MCC 1274 (FERM BP-11175) for producing a composition for anti-obesity treatment or amelioration of glucose tolerance.
Patent NZ-603071-A (NZ)
Title: Use of histamine h4 antagonist for the treatment of post-operative adhesions
Inventor: THURMOND ROBIN L
IPC: A61K31/4184
Filed: 2009-06-11
Abstract: The disclosure relates to the use of at least one histamine H4 receptor antagonist in the preparation of a medicament for the inhibition of post-operative adhesion formation in a body between tissue surfaces in a body cavity having been subjected to a surgical procedure, wherein the at least one histamine H4 receptor antagonist is selected from the group consisting of benzofuro- and benzothienopyrimidines; pharmaceutically acceptable salts, hydrates, solvates and mixtures of any of said H4 receptor antagonists.
Patent NZ-603190-A (NZ)
Title: Methods and computer systems for determining a dna match between dna samples
Inventor: BILL MARTIN
IPC: G01N33/48
Filed: 2004-07-09
Abstract: 603190 A computer implemented method and computer system for determining a DNA sample match between first and second DNA samples. The data sets data sets arise from the analysis of DNA samples, in which both first and second data set are compared with one another. The comparison occurs before any processing of the data has occurred. In this way an empirical analysis of the data is provided which does not introduce any of the errors or data omissions inherent in an interpretive approach to data analysis.
Patent NZ-612533-A (NZ)
Title: Granzyme b inhibitor compositions, methods and uses for promoting wound healing
Inventor: HIEBERT PAUL R
IPC: C12N9/64
Filed: 2011-12-06
Abstract: Disclosed is the use of a Granzyme B inhibitor in the preparation of a medicament for promoting wound healing, preventing skin tearing, inhibiting hypertrophic scarring of a wound, increasing the tensile strength of a healing wound, or increasing the tensile strength of a healed skin wound.
Patent NZ-617611-A (NZ)
Title: Microwaveable batter
Inventor: PICKFORD KEITH
IPC: A23L7/157
Filed: 2012-05-30
Abstract: A microwave cookable or reheatable foodstuff coating composition consisting 55 to 80 wt% water and 20 to 45 wt% by dry weight of an ingredient mixture including: a. 35 to 60 wt% of a flour component selected from a group consisting of rice flour and rice flour with one or more of soy flour, maize flour and wheat flour; b. 15 to 35 wt% of non-modified starch; c. 0.1 to 5 wt% of a gelling agent; d. 0 to 15 wt% of modified starch; and e. 0 to 35 wt% of other edible ingredients. The gelling agent may be collagen, alginate, xanthan gum, gelatine, guar gum, agar gum, gum arabic, locust bean gum or carrageenan and the other ingredient may be egg solids, preferably egg solids from egg material selected from whole egg, egg yolk and egg white.
Patent NZ-617995-A (NZ)
Title: Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
Inventor: BAUMEISTER JUDITH
IPC: G01N33/563
Filed: 2012-06-25
Abstract: Disclosed is a protein or polypeptide for use in therapy, said protein or polypeptide having a half-life, expressed as t1/2-beta, in a human subject of at least 3 days, the protein or polypeptide containing an immunoglobulin single variable domain (ISV) at its C-terminal end, wherein said ISV is a VHH, sequence optimised VHH, humanised VHH or camelised VH, or is an ISV that comprises a VH sequence or that is derived from a VH sequence, the ISV having a C-terminal end of the sequence VTVSS(X)n, in which: - n = 1, 2 or 3 in which each X = Ala or Gly; or - n = 1, 2 or 3 in which each X = Ala; or - n = 1, 2 or 3 in which each X = Gly; or - n = 2 or 3 in which at least one X = Ala or Gly, with the remaining amino acid residue X being independently chosen from any naturally occurring amino acid; or - n = 2 or 3 in which all but one X = Ala or Gly, with the remaining amino acid residue X being independently chosen from any naturally occurring amino acid. Also disclosed is a protein or polypeptide for use in therapy that has a half-life, expressed as t1/2-beta, in a human subject of at least 3 days, said protein or polypeptide containing an ISV at its C-terminal end, wherein said ISV is a VHH, sequence optimised VHH, humanised VHH or camelised VH, or is an ISV that comprises a VH sequence other than VHH, sequence optimised VHH, humanised VHH or camelised VH or that is derived from a VH sequence, said ISV having a C-terminal end of the sequence VTVSS(X)n, in which n is 1 to 10, and in which each X is an amino acid residue that is independently chosen with the proviso that X is not cysteine; or a protein or polypeptide which contains such an ISV at its C-terminal end.
Patent NZ-621615-A (NZ)
Title: N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
Inventor: SCHWAB WILFRIED
IPC: C07D417/12
Filed: 2012-09-26
Abstract: The present disclosure relates to an improved and shortened synthesis of N-[5- (aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acet-amide and the mesylate monohydrate salt thereof by using boronic acid derivatives or borolane reagents while avoiding toxic organic tin compounds and to the mesylate monohydrate salt of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N- methyl-2-[4-(2-pyridinyl)phenyl]acet-amide which has demonstrated increased long term stability and release kinetics from pharmaceutical compositions.
Patent NZ-623345-A (NZ)
Title: Systems and methods for predicting response to minoxidil for the treatment of androgenetic alopecia
Inventor: TAM PHILLIP Y
IPC: C12Q1/48
Filed: 2012-09-26
Abstract: A method for selecting a treatment for a subject suffering from androgenetic alopecia is disclosed. The method comprises performing an assay to measure minoxidil sulfotransferase activity in the sample of one or more hair follicles or a scalp biopsy previously obtained from the subject, thereby generating an activity value indicative of the minoxidil sulfotransferase activity level in the sample; comparing the activity value to one or more standardized activity values with each standardized activity value representing either high or low expected minoxidil response for hair re-growth or retention for a class of patients including the subject, thereby producing an indication of either high or low expected minoxidil response for hair re-growth or retention for the subject at a particular dosage of minoxidil; and presenting the indication to the subject.
Patent NZ-630248-A (NZ)
Title: Solubilized capsule formulation of 1,1-dimethylethyl [(1s)-1-{ [(2s,4r)-4-(7-chloro-4methoxyisoquinolin-1-yloxy)-2-({ (1r,2s)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl} carbamoyl)pyrrolidin-1-yl]carbonyl} -2,2-dimethylpropyl]carbamate
Inventor: PERRONE ROBERT KEVIN
IPC: A61P31/14
Filed: 2013-04-30
Abstract: The present disclosure includes various embodiments directed to a solubilised capsule formulation of asunaprevir, 1,1-dimethylethyl [(1S)-1-{ [(2S,4R)-4-(7-chloro-4methoxyisoquinolin-1-yloxy)-2-({ (1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl} carbamoyl)pyrr olidin-1-yl]carbonyl} -2,2-dimethylpropyl]carbamate, and to methods of treating hepatitis C virus (HVC) infection. The formulations are solubilised by medium-chain fatty acid triglycerides, combinations of mono, di and triglycerides of long-chain fatty acids; mono- and di- long-chain fatty acid esters of polyethylene glycol (commonly known as polyoxyethylated glycerides, i.e., oleoyl polyoxylglycerides and linoleoyl polyoxylglycerides); glycerol monocaprylocaprate, glycerol monocaprylate, glycerol mono/dicaprate, and the propylene glycol mono- and diesters of medium-chain fatty acids such as propylene glycol monocaprylate, propylene glycol monolaurate, propylene glycol dilaurateand, and combinations thereof.
Patent NZ-702303-A (NZ)
Title: High power optical switch
Inventor: SMITH IRL W
IPC: H04Q11/00
Filed: 2013-05-24
Abstract: An optical switch capable of routing a high-power beam incident at one or more input ports of the optical switch to either of two or more output ports, the optical switch comprising: at least one switching stage, each of the at least one switching stages comprising: a switchable high-power liquid crystal (LC) half-wave plate (HWP), oriented with its fast axis at 45° to an input polarization direction such that in response to an incident polarized laser beam provided to said switchable high-power liquid crystal, halfwave plate, said HWP acts as a polarization rotator; a polarizing beam splitter (PBS) disposed in an optical path to intercept light signals output from said switchable highpower liquid crystal (LC) half-wave plate (HWP); a collimating lens disposed at an output of at least one of said at least one switching stages; and at the output of each of said at least one switching stages having a collimating lens coupled thereto, a tip/tilt/focus optical phased array (TTFOPA) disposed between an output of a PBS of each of said at least one switching stages and said respective collimating lens, wherein the TTFOPA comprises two optical phased arrays with approximately perpendicular steering axes.
Patent NZ-702721-A (NZ)
Title: Vaccination with interleukin-4 antagonists
Inventor: JACKSON RONALD JAMES
IPC: A61P31/18
Filed: 2013-06-05
Abstract: The invention relates to compositions and uses thereof for inducing an antigen-specific immune response, for increasing the avidity of immune cells for an antigen, for increasing the number of immune cells specific for an antigen in a subject, or for preventing or treating infection or vaccinating a subject, wherein the compositions and uses comprise an interleukin-4 receptor (IL-4R) antagonist in combination with an antigen, in particular an HIV-1 antigen selected from a gag, pol, or env protein, wherein one or more polynucleotides encoding the antigen and the interleukin-4 receptor antagonist are a component of a recombinant virus and are expressed in the subject in a priming dose and a booster dose, and the recombinant virus of the priming dose and the booster dose transiently expresses the interleukin-4 receptor antagonist in the subject.
Patent NZ-746348-A (NZ)
Title: System for side insertion of a bicondylar mini knee implant
Inventor: TERMANINI ZAFER
IPC: A61F2/38
Filed: 2017-02-16
Abstract: Knee arthroplasty and resurfacing knee implants have been in use now for many decades. The procedure usually requires the operating surgeon to prepare the end of the tibial and femoral bones to receive the implant. This preparation requires the careful removal of the articular surface and adjacent bone in order to receive the intended implant. The invention provides a bicondylar knee implants with improved fixation means for resurfacing only the weight-bearing surface of the femoral medial and lateral condyles, while preserving the cruciate ligaments and avoids displacing the patella. The inventive device includes metallic convex articular surfaces for resurfacing the medial and lateral femoral condyles, and concave multifacial non-articular surfaces to be affixed to the resected distal surfaces of the femur. The prosthesis provides claws situated at the anterior and posterior ends of the medial and lateral metallic condyles, which will firmly attach the implant against the resected femoral condyle. The prosthesis is designed to be implanted through a direct lateral approach and does not resurface the femoropatellar joint.
Patent NZ-765862-A (NZ)
Title: Direct coupling compatible sprinkler
Inventor: BANCROFT PHILIP
IPC: A62C37/14
Filed: 2017-08-08
Abstract: A sprinkler adapted to receive arcuate surfaces of a grooved coupling, said sprinkler being retainable to said coupling in a pre-assembled state for joining said sprinkler in facing axial end-to-end relation directly to grooved pipe, said sprinkler, comprising: a monolithic body defining a bore having an inlet and an outlet oppositely disposed, said bore being open at said inlet; a first arm extending from said body adjacent to said outlet, said first arm having an end positioned in spaced relation to said outlet; a closing member sealingly engaging said outlet; a trigger positioned between said end of said first arm and said closing member, said trigger permitting opening of said closing member; a groove extending around said body, said groove being positioned in said body between said inlet and said outlet, said groove being adapted to receive said arcuate surfaces; a projection projecting outwardly from said body, said projection being positioned between said groove and said outlet.
Patent PT-100969-A (PT)
Title: Deep water wave energy collector, generator drive and anchor - uses hollow annuloid shell with wave ingress and air containment and ducting with canopy partially filled with sediment
Inventor: WELLS ALAN ARTHUR
IPC: E02D23/16
Filed: 1992-10-15
Abstract: The wave energy collector structure towable to a marine site is anchored by sediment (237) pumped from the sea bed (215) into the base (221) of the structure. The sediment may be stabilised. A three cell sphere tetrahedron collector has one or more openings for the ingress of waves. To optimise air flow, the upper canopy has radial dividers whose lower edges extend below the water line. Ducts convey air to ensure constant turn direction of a rotor which extracts available power efficiently using pref. 9 to 15 rotor blades. These are catenary shaped to balance centrifugal and blade tension forces.
Patent PT-101747-A (PT)
Inventor: OSBORN THOMAS WARD III
IPC: A61F13/476
Filed: 1995-07-27
Abstract: The present invention relates to absorbent articles such as female sanitary napkins, adult incontinence devices, and the like. Still more particularly, the present invention concerns absorbent articles having flaps and zones of differential extensibility for relieving the stresses that develop in the flaps when the flaps are folded down and under a wearer's undergarment. The zones of differential extensibility are not exclusively made of precorrugated or ring-rolled portions.  <IMAGE>
Patent PT-103222-A (PT)
Title: Production of sulfonyl ureas for agriculture comprises in situ formation of alkyl carbamate and addition of sulfonamide
Inventor: FLORBELA PEREIRA
IPC: C07D239/48
Filed: 2004-12-29
Abstract: Production of sulfonyl ureas comprises in situformation of alkyl N-triazinyl or N-pyrimidyl carbamates using alkyl carbonates, with subsequent addition of sulfonamide.
Patent PT-104134-A (PT)
Title: Sistema de perfis e/ou dispositivos para montagem em prateleiras, para apresentação de informação
Inventor: ALVES MANUEL
IPC: G09F3/20
Filed: 2008-07-18
Abstract: O PRESENTE INVENTO DIZ RESPEITO A UM SISTEMA DE PERFIS E/OU DISPOSITIVOS PARA MONTAGEM EM PRATELEIRAS, PARA APRESENTAÇÃO DE INFORMAÇÃO, COMO RÓTULOS, MARCAS, ETIQUETAS DE PREÇOS, E/OU OUTRA QUALQUER INFORMAÇÃO SOBRE OS PRODUTOS EXPOSTOS NAS REFERIDAS PRATELEIRAS, O REFERIDO SISTEMA COMPORTANDO MEIOS DE FIXAÇÃO ÀS PRATELEIRAS E DE FIXAÇÃO E SUPORTE DOS PERFIS E/OU DOS DISPOSITIVOS. É ESSENCIALMENTE CARACTERIZADO POR SER CONSTITUÍDO POR UM PERFIL-MATRIZ (1) QUE COMPORTA DUAS SECÇÕES DISTINTAS (5 E 6), UMA POSTERIOR (5) PARA MONTAGEM E FIXAÇÃO NAS PRATELEIRAS, OUTRA ANTERIOR (6) PARA MONTAGEM E FIXAÇÃO DOS PERFIS (2 E 3) E/OU DOS DISPOSITIVOS (4), SENDO A SECÇÃO POSTERIOR (5) DE MONTAGEM NAS PRATELEIRAS DIFERENTE CONSOANTE O TIPO DE PRATELEIRA, E POR A SECÇÃO ANTERIOR (6) APRESENTAR UMA CONFIGURAÇÃO COM UMA SUPERFÍCIE ENCURVADA (7) E COM MEIOS DE ENCAIXE (8 E 9) TAIS QUE VÃO PERMITIR O ACOPLAMENTO DOS PERFIS (2 E 3) E/OU DOS DISPOSITIVOS (4) DE SUPORTE DE INFORMAÇÃO, SEPARADAMENTE OU EM CONJUNTO, E EM SOBREPOSIÇÃO, PODENDO ESTES PERFIS (2 E 3) E ESTES DISPOSITIVOS (4) SER DISTRIBUÍDOS AO LONGO DE TODO O COMPRIMENTO DO PERFIL-MATRIZ (1).
Patent PT-104215-A (PT)
Title: Sistema de pagamento em parques de estacionamento com dispositivos de comunicação de proximidade sem contacto
Inventor: FONSECA JOSE ALBERTO GOUVEIA
IPC: G07F17/24
Filed: 2008-10-15
Abstract: O PRESENTE INVENTO, DIZ RESPEITO A UM SISTEMA DE PRÉ-PAGAMENTO EM PARQUES DE ESTACIONAMENTO, EM QUE O UTILIZADOR POSSUI UM DISPOSITIVO DE COMUNICAÇÃO DE PROXIMIDADE SEM CONTACTO (CARTÃO OU OUTRO). ESTE DISPOSITIVO É PREVIAMENTE CARREGADO, E QUANDO O UTILIZADOR DESEJAR INICIAR UM ESTACIONAMENTO, APROXIMA O DISPOSITIVO DO POSTO DE PAGAMENTO DANDO INÍCIO À CONTAGEM DO TEMPO DE ESTACIONAMENTO. QUANDO PRETENDER TERMINAR O ESTACIONAMENTO, VOLTA A APROXIMAR O DISPOSITIVO DO POSTE DE PAGAMENTO, É RETIRADO AO SEU SALDO O VALOR CORRESPONDENTE AO TEMPO DECORRIDO. A ENTIDADE EXPLORADORA POSSUI UM DISPOSITIVO QUE COMUNICA COM OS POSTOS DE PAGAMENTO, TENDO ACESSO ÀS MATRÍCULAS DOS UTILIZADORES COM O PAGAMENTO VÁLIDO, PODENDO IDENTIFICAR ASSIM OS UTILIZADORES PREVARICADORES. O INVENTO PODE SER APLICADO A PARQUES DE ESTACIONAMENTO FECHADOS, DE CANCELA, OU A PARQUES DE ESTACIONAMENTO ABERTOS, DE RUA. AS FUNCIONALIDADES DISPONÍVEIS PODEM SER CONFIGURADAS, DE ACORDO COM AS NECESSIDADES DOS UTILIZADORES E DOS EXPLORADORES.
Patent PT-106850-A (PT)
Title: Sistema de rotura aplicado em cápsulas para máquinas de café expresso, chá ou outros solúveis, fabricadas em material termo plástico, alumínio ou materiais similares
Inventor: OSCAR DE DEUS TELES DE NORONHA GALV O
IPC: B65D85/804
Filed: 2013-03-25
Abstract: SISTEMA DE ROTURA PARA SER APLICADO EM CÁPSULAS PARA MÁQUINAS DE CAFÉ EXPRESSO, CHÁ OU OUTROS SOLÚVEIS, FABRICADAS EM MATERIAL TERMO PLÁSTICO, ALUMÍNIO OU MATERIAIS SIMILARES. ESTE SISTEMA PODE SER APLICADO NAS ZONAS DE ENTRADA E SAÍDA DA INFUSÃO DA CÁPSULA, OU APENAS NUMA DELAS. A SUPERFÍCIE REBAIXADA DO FUNDO DO COPO, APRESENTA PELO INTERIOR VINCOS CAVADOS (1), QUE REDUZEM A ESPESSURA DA PAREDE E LIMITAM ÁREAS DE ROTURA QUE É PROVOCADA PELA PRESSÃO DA BOMBA DE ÁGUA; A TAMPA FABRICADA NO MESMO MATERIAL, APRESENTA OS VINCOS DE ROTURA PELO EXTERIOR QUE PODEM SER IGUAIS AOS DO INTERIOR DO COPO, OU SER DIFERENTES, COM GEOMETRIA E QUANTIDADE ADEQUADA À GRANULARIDADE DOS PRODUTOS INTRODUZIDOS NA CÁPSULA. A PAREDE (5) COM TEXTURA RUGOSA, APRESENTA NERVURAS INTERIORES E NO ÚLTIMO TERÇO DA PAREDE COM PROLONGAMENTO PARA O INTERIOR, APRESENTA TRÊS OU MAIS ABAS (6); A TAMPA (2) APRESENTA ABA INVERTIDA COM FECHO HERMÉTICO.
Patent RO-88130-A (RO)
Inventor: PEIGNIER MICHEL
IPC: C08L5/00
Filed: 1983-07-29
Abstract: Storage-stable, pumpable, concentrated polymer suspensions, well adapted for use as thickening and flocculating agents, are comprised of (i) a water-soluble polymer, (ii) at least one water-soluble surfactant, and (iii) water, the amount of water being less than about 30% by weight of the total weight thereof.